27 related articles for article (PubMed ID: 11502727)
1.
Eckernäs E; Macan-Schönleben A; Andresen-Bergström M; Birgersson S; Hoffmann KJ; Ashton M
Xenobiotica; 2023 Dec; 53(8-9):515-522. PubMed ID: 37916667
[No Abstract] [Full Text] [Related]
2. Discovery of a Novel Lidocaine Metabolite by Human Liver Microsome and Identification of Microbial Species Which Produces the Same Metabolite.
Hori S; Taniguchi H; Yoshimura S; Takeda K; Yamashita R; Kimishima A; Harada K
Chem Pharm Bull (Tokyo); 2024; 72(4):393-398. PubMed ID: 38644165
[TBL] [Abstract][Full Text] [Related]
3. Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes.
Ghosal A; Hapangama N; Yuan Y; Lu X; Horne D; Patrick JE; Zbaida S
Biopharm Drug Dispos; 2003 Dec; 24(9):375-84. PubMed ID: 14689466
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4.
Stresser DM; Turner SD; Blanchard AP; Miller VP; Crespi CL
Drug Metab Dispos; 2002 Jul; 30(7):845-52. PubMed ID: 12065444
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes.
Yamamoto T; Suzuki A; Kohno Y
Xenobiotica; 2003 Aug; 33(8):823-39. PubMed ID: 12936703
[TBL] [Abstract][Full Text] [Related]
6. Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro.
Raunio H; Pentikäinen O; Juvonen RO
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630278
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of Benzalkonium Chlorides by Human Hepatic Cytochromes P450.
Seguin RP; Herron JM; Lopez VA; Dempsey JL; Xu L
Chem Res Toxicol; 2019 Dec; 32(12):2466-2478. PubMed ID: 31730751
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation of Safety of Fucoidan Extracts From
Bovet L; Samer C; Daali Y
Integr Cancer Ther; 2019; 18():1534735419876325. PubMed ID: 31522564
[No Abstract] [Full Text] [Related]
9. Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences.
Davydov DR; Davydova NY; Rodgers JT; Rushmore TH; Jones JP
Biochem J; 2017 Oct; 474(20):3523-3542. PubMed ID: 28904078
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6(*)1 and CYP2D6(*)10 using cell-based models in vitro.
Qu Q; Qu J; Han L; Zhan M; Wu LX; Zhang YW; Zhang W; Zhou HH
Acta Pharmacol Sin; 2014 May; 35(5):685-96. PubMed ID: 24786236
[TBL] [Abstract][Full Text] [Related]
11. Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6.
Livezey MR; Briggs ED; Bolles AK; Nagy LD; Fujiwara R; Furge LL
Xenobiotica; 2014 Apr; 44(4):309-319. PubMed ID: 24010633
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells.
Mann A; Tyndale RF
Eur J Neurosci; 2010 Apr; 31(7):1185-93. PubMed ID: 20345925
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening assays for CYP2B6 metabolism and inhibition using fluorogenic vivid substrates.
Marks BD; Goossens TA; Braun HA; Ozers MS; Smith RW; Lebakken C; Trubetskoy OV
AAPS PharmSci; 2003; 5(2):E18. PubMed ID: 12866948
[TBL] [Abstract][Full Text] [Related]
14. The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.
Chauret N; Dobbs B; Lackman RL; Bateman K; Nicoll-Griffith DA; Stresser DM; Ackermann JM; Turner SD; Miller VP; Crespi CL
Drug Metab Dispos; 2001 Sep; 29(9):1196-200. PubMed ID: 11502727
[TBL] [Abstract][Full Text] [Related]
15. Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe.
Chauret N; Tremblay N; Lackman RL; Gauthier JY; Silva JM; Marois J; Yergey JA; Nicoll-Griffith DA
Anal Biochem; 1999 Dec; 276(2):215-26. PubMed ID: 10603245
[TBL] [Abstract][Full Text] [Related]
16. Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity.
Venhorst J; Onderwater RC; Meerman JH; Commandeur JN; Vermeulen NP
Drug Metab Dispos; 2000 Dec; 28(12):1524-32. PubMed ID: 11095593
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of BYZX in human liver microsomes and the structural elucidation of metabolite by liquid chromatography-mass spectrometry method.
Xia ZL; Ying JY; Sheng R; Zeng S; Hu YZ; Yao TW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):266-74. PubMed ID: 17709305
[TBL] [Abstract][Full Text] [Related]
18. Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms.
Makaji E; Trambitas CS; Shen P; Holloway AC; Crankshaw DJ
Toxicol Sci; 2010 Feb; 113(2):293-304. PubMed ID: 19858067
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine.
Obach RS; Pablo J; Mash DC
Drug Metab Dispos; 1998 Aug; 26(8):764-8. PubMed ID: 9698290
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
